John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$233M |
| 2 |
Amgen
AMGN
|
+$231M |
| 3 |
Airbnb
ABNB
|
+$231M |
| 4 |
Costco
COST
|
+$210M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$263M |
| 2 |
Lowe's Companies
LOW
|
+$218M |
| 3 |
Wayfair
W
|
+$217M |
| 4 |
PepsiCo
PEP
|
+$217M |
| 5 |
Verizon
VZ
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.69% |
| 2 | Technology | 15.24% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 9.17% |
| 5 | Financials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAG
3951
Adagene
ADAG
$258M
| – | – |
-20,232
| Closed | -$363K |
|
3952
Adobe
ADBE
$110B
| – | – |
-5,538
| Closed | -$2.85M |
|
3953
Adaptive Biotechnologies
ADPT
$4.08B
| – | – |
-203,685
| Closed | -$8.2M |
|
3954
ADT
ADT
$5.42B
| – | – |
-28,305
| Closed | -$239K |
|
3955
CALL
Agnico Eagle Mines
AEM
$110B
| – | – |
-20,000
| Closed | -$1.16M |
|
|
3956
Agnico Eagle Mines
AEM
$110B
| – | – |
-411,214
| Closed | -$23.8M |
|
|
3957
PUT
Agnico Eagle Mines
AEM
$110B
| – | – |
-21,100
| Closed | -$1.22M |
|
3958
American Financial Group
AFG
$12B
| – | – |
-76,464
| Closed | -$8.72M |
|
3959
Aflac
AFL
$59.3B
| – | – |
-46,394
| Closed | -$2.37M |
|
3960
CALL
First Majestic Silver
AG
$10.3B
| – | – |
-41,100
| Closed | -$640K |
|
|
3961
PUT
First Majestic Silver
AG
$10.3B
| – | – |
-49,600
| Closed | -$773K |
|
3962
PUT
AGNC Investment
AGNC
$13B
| – | – |
-13,100
| Closed | -$220K |
|
3963
Assured Guaranty
AGO
$3.26B
| – | – |
-4,927
| Closed | -$231K |
|
3964
AdaptHealth
AHCO
$751M
| – | – |
-89,682
| Closed | -$3.3M |
|
3965
C3.ai
AI
$1.57B
| – | – |
-30,110
| Closed | -$1.99M |
|
3966
PUT
Assurant
AIZ
$14.2B
| – | – |
-3,300
| Closed | -$468K |
|
3967
CALL
Akamai
AKAM
$15.2B
| – | – |
-10,300
| Closed | -$1.05M |
|
|
3968
PUT
Akamai
AKAM
$15.2B
| – | – |
-9,100
| Closed | -$927K |
|
3969
Akebia Therapeutics
AKBA
$250M
| – | – |
-626,577
| Closed | -$2.12M |
|
3970
Alcon
ALC
$35.6B
| – | – |
-304,610
| Closed | -$21.7M |
|
3971
Albemarle
ALB
$16.7B
| – | – |
-3,600
| Closed | -$581K |
|
|
ALE
3972
DELISTED
Allete
ALE
| – | – |
-74,909
| Closed | -$5.03M |
|
3973
PUT
Align Technology
ALGN
$11.3B
| – | – |
-1,000
| Closed | -$542K |
|
3974
CALL
Alaska Air
ALK
$4.64B
| – | – |
-4,500
| Closed | -$311K |
|
|
3975
PUT
Alaska Air
ALK
$4.64B
| – | – |
-4,000
| Closed | -$277K |
|
Similar funds
John Overdeck's Q2 2021 Portfolio in Review
As of Q2 2021, John Overdeck held 4,837 positions worth $44.1B, up 15% from $38.4B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.
John Overdeck deployed $2.44B of net new capital in Q2 2021, opening 1,073 new positions and adding to 1,470 existing holdings. Its largest new stake was Amgen: 939,881 shares worth $229M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Verizon, an estimated $206M trimmed.
- John Overdeck's largest Q2 2021 buy was Amgen: 939,881 shares worth $229M.
- John Overdeck added most to Starbucks in Q2 2021, an estimated $233M increase.
- John Overdeck's biggest Q2 2021 reduction was Verizon, cutting an estimated $206M.
- John Overdeck fully exited Amazon in Q2 2021, selling an estimated $263M.
- John Overdeck's ten largest holdings make up 6.1% of its $44.1B portfolio in Q2 2021.
- John Overdeck opened 1,073 new positions and closed 875 in Q2 2021.
- John Overdeck's portfolio value rose 15% quarter-over-quarter to $44.1B.
Based on Two Sigma Investments's 13F filing for Q2 2021, filed 16 Aug 2021.